Compounds > eosine yellowish-(ys)
Page last updated: 2024-08-21

eosine yellowish-(ys) and Non-alcoholic Fatty Liver Disease

eosine yellowish-(ys) has been researched along with Non-alcoholic Fatty Liver Disease in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's4 (100.00)2.80

Authors

AuthorsStudies
Feng, Y; Liu, H; Ping, J; Wen, X; Xu, D; Zhao, W1
Dong, Y; Shen, S; Wang, K; Zhi, Y1
Chalasani, N; Cummings, OW; Gawrieh, S; Kleiner, DE; Sethunath, D; Tuceryan, M; Vuppalanchi, R1
Andersen, MJ; Azizgolshani, N; Bobak, CA; Christensen, BC; Levy, JJ; Lisovsky, M; Liu, X; Ren, B; Suriawinata, A; Vaickus, LJ1

Other Studies

4 other study(ies) available for eosine yellowish-(ys) and Non-alcoholic Fatty Liver Disease

ArticleYear
Pentoxifylline attenuates nonalcoholic fatty liver by inhibiting hepatic macrophage polarization to the M1 phenotype.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2022, Volume: 106

    Topics: Animals; Cholesterol; Eosine Yellowish-(YS); Glucose; Insulin Resistance; Insulins; Lipopolysaccharides; Liver; Macrophages; Mice; Molecular Docking Simulation; Myeloid Differentiation Factor 88; NF-kappa B; Non-alcoholic Fatty Liver Disease; Pentoxifylline; Phenotype; Tea; Theobromine; Toll-Like Receptor 4; Triglycerides

2022
Gypenosides counteract hepatic steatosis and intestinal barrier injury in rats with metabolic associated fatty liver disease by modulating the adenosine monophosphate activated protein kinase and Toll-like receptor 4/nuclear factor kappa B pathways.
    Pharmaceutical biology, 2022, Volume: 60, Issue:1

    Topics: Adenosine Monophosphate; AMP-Activated Protein Kinases; Animals; Caco-2 Cells; Eosine Yellowish-(YS); Fructose; Glucose; Gynostemma; Humans; Lipopolysaccharides; Liver; NF-kappa B; Non-alcoholic Fatty Liver Disease; Occludin; Plant Extracts; Rats; Rats, Sprague-Dawley; Toll-Like Receptor 4

2022
Automated quantification and architectural pattern detection of hepatic fibrosis in NAFLD.
    Annals of diagnostic pathology, 2020, Volume: 47

    Topics: Artificial Intelligence; Automation; Azo Compounds; Biopsy; Clinical Trials as Topic; Collagen; Eosine Yellowish-(YS); Fibrosis; Humans; Image Processing, Computer-Assisted; Liver; Liver Cirrhosis; Methyl Green; Non-alcoholic Fatty Liver Disease; Organ Dysfunction Scores; Pathologists; Portal Vein; Practice Patterns, Physicians'; Severity of Illness Index; Supervised Machine Learning

2020
A large-scale internal validation study of unsupervised virtual trichrome staining technologies on nonalcoholic steatohepatitis liver biopsies.
    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 2021, Volume: 34, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azo Compounds; Biopsy; Child; Clinical Decision-Making; Coloring Agents; Decision Support Techniques; Eosine Yellowish-(YS); Female; Hematoxylin; Humans; Image Interpretation, Computer-Assisted; Liver; Liver Cirrhosis; Male; Methyl Green; Microscopy; Middle Aged; Neural Networks, Computer; Non-alcoholic Fatty Liver Disease; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; Severity of Illness Index; Software; Staining and Labeling; Young Adult

2021